Guru Ownership Trend
Guru Analysis for Eton Pharmaceuticals, Inc. (ETON)
Eton Pharmaceuticals, Inc. (ETON), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $5.98 M.
Top institutional holders include Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $3.26 M net outflow during the quarter.
On the selling side, Renaissance Technologies (RenTech) reduced exposure by 20.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Eton Pharmaceuticals, Inc. (ETON)
Major holders include Renaissance Technologies (RenTech) ($4.03 M). According to the latest reported data, 1 tracked investment managers collectively hold approximately 163,321 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $3.26 M, with 0 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 2 fully exited ETON. The total reported sell value was $3.26 M.
No tracked managers opened new positions or increased their holdings in ETON during the most recent reporting period.